3 assets in Malignant Epithelial Tumor Of Ovary

Therapeutic assets addressing Malignant Epithelial Tumor Of Ovary, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Niraparib Malignant Epithelial Tumor Of Ovary	CanariaBio Inc.	P2	CCC (53)
Oregovamab Malignant Epithelial Tumor Of Ovary	CanariaBio Inc.	P2	CC (47)
Dordaviprone Malignant Epithelial Tumor Of Ovary	Ira Winer	P2	CC (45)